Holen Sie sich die Stockscreener-App
85.47
0.75%
-0.68
Schlusskurs vom Vortag:
$86.15
Offen:
$86.21
24-Stunden-Volumen:
156.79K
Relative Volume:
1.63
Marktkapitalisierung:
$N/A
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
+0.79%
1M Leistung:
+2.88%
6M Leistung:
+28.73%
1J Leistung:
+30.26%
1-Tages-Spanne:
$85.46
$87.02
1-Wochen-Bereich:
$83.03
$87.02
52-Wochen-Spanne:
$58.97
$87.02
Ishares U S Pharmaceuticals Etf Stock (IHE) Company Profile
Firmenname
Ishares U S Pharmaceuticals Etf
Sektor
Branche
Telefon
-
Adresse
-
Vergleichen Sie IHE mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
IHE
Ishares U S Pharmaceuticals Etf
|
85.48 | 0 | 0 | 0 | 0 | 0.00 |
|
VTI
Vanguard Total Stock Market Etf
|
339.92 | 417.53B | 0 | 0 | 0 | 0.00 |
|
SPY
Spdr S P 500 Etf Trust
|
689.03 | 372.57B | 0 | 0 | 0 | 0.00 |
|
IVV
Ishares Core S P 500 Etf
|
692.09 | 253.41B | 0 | 0 | 0 | 0.00 |
|
VB
Vanguard Small Cap Etf
|
269.18 | 160.59B | 0 | 0 | 0 | 0.00 |
|
QQQ
Invesco Qqq Trust Series 1
|
619.34 | 124.43B | 0 | 0 | 0 | 0.00 |
Ishares U S Pharmaceuticals Etf Aktie (IHE) Neueste Nachrichten
Should You Invest in the iShares U.S. Pharmaceuticals ETF (IHE)? - Yahoo Finance
4 Top-Ranked ETF Areas That Beat the Market in 2025 - The Globe and Mail
Bet on These Top-Ranked Healthcare ETFs Before 2025 Ends - The Globe and Mail
Should You Invest in the Invesco Pharmaceuticals ETF (PJP)? - sharewise.com
Aug Opening: Is iShares U.S. Pharmaceutical ETF stock a top pick for value investorsPortfolio Update Report & Free Growth Oriented Trading Recommendations - Улправда
Why Health Care ETFs Aren't Panicking Over Big Pharma's Price Cuts - Benzinga
Pharma's $370B Bet on America: The ETF Plays for 2026 - The Globe and Mail
iShares Dow Jones US Pharmaceuticals ETF (IHE) Stock News & Articles - 24/7 Wall St.
Short bets on S&P 500 healthcare sector rises to 2.12% in November; MRNA stays most shorted stock - MSN
3 dividend ETFs to buy and hold for life if the market crashes - MSN
3 Dividend ETFs to Buy and Hold for Life if the Market Crashes - AOL.com
Pharma ETFs to Gain From Landmark UK-US Zero-Tariff Deal - sharewise.com
iShares U.S. Pharmaceuticals ETF $IHE Shares Sold by Brown Advisory Inc. - Defense World
The pharmaceutical sector is surging. Here's 1 stock every investor should have on their radar. - MSN
The Pharmaceutical Sector Is Surging. Here's 1 Stock Every Investor Should Have on Their Radar. - The Globe and Mail
Tema’s Oncology ETF (CANC) Surpasses $100m in Assets Amidst Strong 2025 Performance - PharmiWeb.com
Pharma ETFs: Your Key to Diversification in the Pharmaceutical Sector - Investing News Network
IHE: Pharma Powerhouse ETF Despite High Fees And Valuation (NYSEARCA:IHE) - Seeking Alpha
Is State Street SPDR S&P Pharmaceuticals ETF (XPH) a Strong ETF Right Now? - sharewise.com
Should You Invest in the VanEck Pharmaceutical ETF (PPH)? - sharewise.com
Novo Nordisk's Stock Slump Shows The GLP‑1 Trade's Side Effect: ETF Concentration Risk - Benzinga
Eli Lilly Hits $1 Trillion Milestone: ETFs to Invest in - TradingView
Eli Lilly Supremacy: How One Stock Is Dictating Performance Across Pharma ETFs - Benzinga
Pharma ETFs in Spotlight Following Robust Q3 Earnings Results - Yahoo Finance
Pharmaceutical Sector Surges on Policy Shifts and Innovation - Ad-hoc-news.de
Pharma Stocks in the World Market for TVC:GOLD by GlobalWolfStreet - TradingView
Eli Lilly CEO Slams PBM 'Rent Taking', Says They Drove Insulin List Prices To $275: 'We Can Disintermediate Them Easily'CVS Health (NYSE:CVS), Cigna Group (NYSE:CI) - Benzinga
Is Invesco Pharmaceuticals ETF (PJP) a Strong ETF Right Now? - sharewise.com
Does Trump's MFN Policy Put Pharma ETFs in the Crosshairs? - sharewise.com
Most S&P 500 healthcare stocks deliver earnings beat this week - MSN
Pharma ETF (IHE) Hit a 52-Week High - sharewise.com
iShares U.S. Pharmaceutical ETF (NY: IHE - Markets Financial Content
ETFs in Focus on Eli Lilly's Solid Q2 Earnings, Weak Obesity Data - MSN
Eli Lilly Extends Lead In $150B Obesity Drug Race As Novo, Pfizer Clash — Here's How ETFs Stand To Gain - NewsBreak: Local News & Alerts
Is iShares U.S. Pharmaceutical ETF stock a top dividend aristocrat candidateEarnings Risk Report & Daily Growth Stock Tips - newser.com
Is iShares U.S. Pharmaceutical ETF stock attractive post correctionJuly 2025 Final Week & Community Consensus Stock Picks - newser.com
Trade Truce Hope: How US-China Talks Could Boost Healthcare ETFs - TradingView
Finanzdaten der Ishares U S Pharmaceuticals Etf-Aktie (IHE)
Es liegen keine Finanzdaten für Ishares U S Pharmaceuticals Etf (IHE) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
0.95%
0.76%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):